First-year intravascular ultrasound results as a surrogate marker for outcomes after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 22, Issue 7, 2003, Pages 711-714

  Kobashigawa, Jon A ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1;

BLOOD VESSEL INJURY; BRAIN DEATH; CELL SURFACE; CHRONIC DISEASE; CORONARY ARTERY; DISEASE MARKER; DONOR; EDITORIAL; ENDOTHELIUM CELL; HEART FAILURE; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; INTRAVASCULAR ULTRASOUND; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PUBLICATION; TREATMENT OUTCOME; UPREGULATION;

EID: 0038164872     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00210-9     Document Type: Editorial

References (20)

1. Hertz M.I., Taylor D.O., Trulock E.P., Boucek M.M., Mohacsi P.J., Edwards L.B., Keck B.M. The registry of the International Society for Heart and Lung Transplantation nineteenth official report - 2002 . J Heart Lung Transplant. 21:(9):2002;950-970.
2. Takada M., Nadeau K.C., Hancock W.W., Mackenzie H.S., Shaw G.D., Waaga A.M., Chandraker A., Sayegh M.H., Tilney N.L. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 65:(12):1998;1533-1542.
3. Mehra M.R., Prasad A., Uber P.A., Park M., Scoot R. The impact of explosive brain death on the genesis of cardiac allograft vasculopathy an intravascular ultrasound study [abstract] . J Heart Lung Transplant. 18:(1):1999;49.
4. Kobashigawa J.A., Miller L., Yeung A., Hauptman P., Ventura H., Wilensky R., Valantine H., Wiedermann J. Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. Sandoz/CVIS investigators. J Heart Lung Transplant. 14:(Suppl):1995;S221-226.
5. Michaels P.J., Espejo M.L., Kobashigawa J., Alejos J.C., Burch C., Takemoto S., Reed E.F., Fishbein M.C. Humoral rejection in cardiac transplantation risk factors, hemodynamic consequences and relationship to transplant coronary artery disease . J Heart Lung Transplant. 22:(1):2003;58-69.
6. Toyoda M., Galfayan K., Galera O.A., Petrosian A., Czer L.S., Jordan S.C. Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients. Transplant Immunol. 5:(2):1997;104-111.
7. Kobashigawa J., Wener L., Johnson J., Currier J.W., Yeatman L., Cassem J., Tobis J. Longitudinal study of vascular remodeling in coronary arteries after heart transplantation. J Heart Lung Transplant. 19:(6):2000;546-550.
8. Bocksch W., Wellnhofer E., Schartl M., Dreysse S., Klimek W., Franke R., Musci M., Hetzer R., Fleck E. Reproducibility of serial intravascular ultrasound measurements in patients with angiographically silent coronary artery disease after heart transplantation. Coron Artery Dis. 11:(7):2000;555-562.
9. Batkoff B.W., Linker D.T. Safety of intracoronary ultrasound data from a Multicenter European Registry . Cathet Cardiovasc Diagn. 38:(3):1996;238-241.
10. Son R., Tobis J.M., Yeatman L.A., Johnson J.A., Wener L.S., Kobashigawa J.A. Does use of intravascular ultrasound accelerate arteriopathy in heart transplant recipients? Am Heart J. 138:(2):1999;358-363.
11. Tuzcu E.M., Kapadia S.R., Tutar E., Ziada K.M., Hobbs R.E., McCarthy P.M., Young J.B., Nissen S.E. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults evidence from intravascular ultrasound . Circulation. 103:(22):2001;2705-2710.
12. Kobashigawa J.A., Katznelson S., Laks H., et al. Effects of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 333:1995;621-627.
13. Wenke K., Meiser B., Thiery J., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation a four-year randomized trial . Circulation. 96:1997;1398-1402.
14. Mehra M.R., Ventura H.O., Smart F.W., Collins T.J., Ramee S.R., Stapleton D.D. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. Am J Cardiol. 75:(12):1995;853-854.
15. Keogh A. Immunosuppression an evolving art and science. TOR inhibitors. Rapamycin: results of a randomized trial following heart transplantation [abstract] . Am J Transplant. 2:(suppl):2002;248.
16. Eisen H., Dorent R., Mancini D., et al. Safety and efficacy of everolimus (RAD) as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients six month analysis [abstract] . J Heart Lung Transplant. 21:2002;55.
17. Mehra M.R., Ventura H.O., Stapleton D.D., Smart F.W., Collins T.C., Ramee S.R. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant. 14:(4):1995;632-639.
18. Rickenbacher P.R., Pinto F.J., Lewis N.P., Hunt S.A., Alderman E.L., Schroeder J.S., Stinson E.B., Brown B.W., Valantine H.A. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation. 92:(12):1995;3445-3452.
19. Mehra M.R., Ventura H.O., Uber P.A., Scott R.L., Park M.H. Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox. J Heart Lung Transplant. 22:(2):2003;118-123.
20. Kapadia S.R., Nissen S.E., Tuzcu E.M. Impact of intravascular ultrasound in understanding transplant coronary artery disease. Curr Opin Cardiol. 14:(2):1999;140-150.